Close Menu

NEW YORK (GenomeWeb) – DermTech announced today that its licensee, DermTech Canada, has received approval to market the company's pigmented lesions assay (PLA) and noninvasive biopsy kit for melanoma detection in Canada.

As part of the approval, DermTech will market and sell the PLA in Canada, while it will process samples at the company's central laboratory in La Jolla, California. The San Diego-based company said that coverage approvals are in process in Canada with an initial focus on British Columbia and Ontario.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Mar
28
Sponsored by
Qiagen

The Human Gene Mutation Database (HGMD) is a manually curated, comprehensive collection of disease-causing, germline mutations. Since 1996, a team of experts has manually catalogued over a quarter of a million mutations for the database.